{"id":2182640,"date":"2026-11-11T07:39:04","date_gmt":"2026-11-11T07:39:04","guid":{"rendered":"https:\/\/www.thebusinessdesk.com\/northwest\/?p=2182640"},"modified":"2026-11-11T07:39:04","modified_gmt":"2026-11-11T07:39:04","slug":"yourgene-health-test-receives-approval-from-australian-regulators","status":"publish","type":"post","link":"https:\/\/www.thebusinessdesk.com\/northwest\/news\/2182640-yourgene-health-test-receives-approval-from-australian-regulators","title":{"rendered":"Yourgene Health test receives approval from Australian regulators"},"content":{"rendered":"<p><span style=\"font-weight: 400\">Novacyt, the French molecular diagnostics company with a growing portfolio of integrated technologies and services including Manchester-based Yourgene Health, has received Australian regulatory approval for its Yourgene Insight DPYD test.<\/span><\/p>\n<p><span style=\"font-weight: 400\">The approval enables Southern Cross Diagnostics Pty, part of the Novacyt Group, to market and supply the in vitro diagnostic assay for its approved clinical diagnostic use in Australia, extending its commercial opportunity beyond research use only to clinical diagnostic testing.<\/span><\/p>\n<p><span style=\"font-weight: 400\">The Therapeutic Goods Administration (TGA) has approved the supply of the Yourgene Insight DPYD assay in Australia.<\/span><\/p>\n<p><span style=\"font-weight: 400\">The assay, manufactured by Yourgene Health, is also certified under the European Union\u2019s In Vitro Diagnostic Regulation (IVDR).<\/span><\/p>\n<p><span style=\"font-weight: 400\">The test detects 19 clinically relevant variants in the DPYD gene, supporting the identification of patients at increased risk of severe or potentially fatal toxicity in patients receiving 5-fluorouracil (5-FU) treatment.<\/span><\/p>\n<p><span style=\"font-weight: 400\">It provides laboratories and clinicians with information to support informed treatment decisions and improve patient management.<\/span><\/p>\n<p><span style=\"font-weight: 400\">The Australian approval builds on the successful launch of the Yourgene Insight DPYD assay as a Research Use Only (RUO) product in<\/span> <span style=\"font-weight: 400\">May 2026, followed by its certification under the IVDR in<\/span> <span style=\"font-weight: 400\">September 2026. TGA approval represents a further step in the product&#8217;s international regulatory expansion, enabling access to another highly regulated market.<\/span><\/p>\n<p><span style=\"font-weight: 400\">TGA approval further extends the commercial reach of the Yourgene Insight DPYD assay, building on its regulatory credentials in Europe and creating additional opportunities to supply laboratories in Australia.<\/span><\/p>\n<p><span style=\"font-weight: 400\">The company estimates that the addressable market for DPYD testing in Australia is approximately 16,000 to 66,000 tests per year.<\/span><\/p>\n<p><span style=\"font-weight: 400\">Based on the current Australian Medicare reimbursement of approximately A$182 per test, <\/span><span style=\"font-weight: 400\">this represents a total annual reimbursed testing value to laboratories of approximately A$3m-12m.<\/span><\/p>\n<p><span style=\"font-weight: 400\">Novacyt CEO, Lyn Rees, said: \u201cAustralian approval expands the commercial opportunity for our Yourgene Insight DPYD assay into routine clinical testing.<\/span><\/p>\n<p><span style=\"font-weight: 400\">\u201cThrough Southern Cross Diagnostics, we can now offer Australian laboratories a registered diagnostic assay to support the identification of patients at increased risk of severe chemotherapy toxicity.<\/span><\/p>\n<p><span style=\"font-weight: 400\">\u201cFollowing IVDR certification in September, this approval advances our international expansion and demonstrates how our Australian distribution business can bring products from across the group to clinical customers.<\/span><\/p>\n<p><span style=\"font-weight: 400\">\u201cWe can bring our established pharmacogenomics testing solution to a wider international customer base and supports our strategy to grow our clinical genetics business and broaden access to pharmacogenomic testing.\u201d<\/span><\/p>\n","protected":false},"excerpt":{"rendered":"<p>Kit can identify patients at increased risk of severe chemotherapy toxicity<\/p>\n","protected":false},"author":217725,"featured_media":2147191,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[120781],"coauthors":[46761],"class_list":["post-2182640","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-markets","tag-featured-story","tag-greater-manchester"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v23.9 - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>Yourgene Health test receives approval from Australian regulators<\/title>\n<meta name=\"description\" content=\"Kit can identify patients at increased risk of severe chemotherapy toxicity\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.thebusinessdesk.com\/northwest\/news\/2182640-yourgene-health-test-receives-approval-from-australian-regulators\" \/>\n<meta property=\"og:locale\" content=\"en_GB\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Yourgene Health test receives approval from Australian regulators\" \/>\n<meta property=\"og:description\" content=\"Kit can identify patients at increased risk of severe chemotherapy toxicity\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.thebusinessdesk.com\/northwest\/news\/2182640-yourgene-health-test-receives-approval-from-australian-regulators\" \/>\n<meta property=\"og:site_name\" content=\"North West\" \/>\n<meta property=\"article:published_time\" content=\"2026-11-11T07:39:04+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.thebusinessdesk.com\/_files\/images\/feb_25\/Lyn-Rees_CEO_Novacyt-e1739529340128.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"1932\" \/>\n\t<meta property=\"og:image:height\" content=\"1287\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"Neil Hodgson\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Neil Hodgson\" \/>\n\t<meta name=\"twitter:label2\" content=\"Estimated reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\/\/www.thebusinessdesk.com\/northwest\/news\/2182640-yourgene-health-test-receives-approval-from-australian-regulators\",\"url\":\"https:\/\/www.thebusinessdesk.com\/northwest\/news\/2182640-yourgene-health-test-receives-approval-from-australian-regulators\",\"name\":\"Yourgene Health test receives approval from Australian regulators\",\"isPartOf\":{\"@id\":\"https:\/\/www.thebusinessdesk.com\/northwest\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/www.thebusinessdesk.com\/northwest\/news\/2182640-yourgene-health-test-receives-approval-from-australian-regulators#primaryimage\"},\"image\":{\"@id\":\"https:\/\/www.thebusinessdesk.com\/northwest\/news\/2182640-yourgene-health-test-receives-approval-from-australian-regulators#primaryimage\"},\"thumbnailUrl\":\"https:\/\/www.thebusinessdesk.com\/_files\/images\/feb_25\/Lyn-Rees_CEO_Novacyt-e1739529340128.jpg\",\"datePublished\":\"2026-11-11T07:39:04+00:00\",\"dateModified\":\"2026-11-11T07:39:04+00:00\",\"author\":{\"@id\":\"https:\/\/www.thebusinessdesk.com\/northwest\/#\/schema\/person\/fa48fb423602cb1966a9a546cfe09356\"},\"description\":\"Kit can identify patients at increased risk of severe chemotherapy toxicity\",\"breadcrumb\":{\"@id\":\"https:\/\/www.thebusinessdesk.com\/northwest\/news\/2182640-yourgene-health-test-receives-approval-from-australian-regulators#breadcrumb\"},\"inLanguage\":\"en-GB\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/www.thebusinessdesk.com\/northwest\/news\/2182640-yourgene-health-test-receives-approval-from-australian-regulators\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-GB\",\"@id\":\"https:\/\/www.thebusinessdesk.com\/northwest\/news\/2182640-yourgene-health-test-receives-approval-from-australian-regulators#primaryimage\",\"url\":\"https:\/\/www.thebusinessdesk.com\/_files\/images\/feb_25\/Lyn-Rees_CEO_Novacyt-e1739529340128.jpg\",\"contentUrl\":\"https:\/\/www.thebusinessdesk.com\/_files\/images\/feb_25\/Lyn-Rees_CEO_Novacyt-e1739529340128.jpg\",\"width\":1932,\"height\":1287,\"caption\":\"Lyn Rees\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/www.thebusinessdesk.com\/northwest\/news\/2182640-yourgene-health-test-receives-approval-from-australian-regulators#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/www.thebusinessdesk.com\/northwest\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Yourgene Health test receives approval from Australian regulators\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/www.thebusinessdesk.com\/northwest\/#website\",\"url\":\"https:\/\/www.thebusinessdesk.com\/northwest\/\",\"name\":\"North West\",\"description\":\"Regional business news for North West\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/www.thebusinessdesk.com\/northwest\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-GB\"},{\"@type\":\"Person\",\"@id\":\"https:\/\/www.thebusinessdesk.com\/northwest\/#\/schema\/person\/fa48fb423602cb1966a9a546cfe09356\",\"name\":\"Neil Hodgson\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-GB\",\"@id\":\"https:\/\/www.thebusinessdesk.com\/northwest\/#\/schema\/person\/image\/25f0ca12630eea7c4ef70e0e79410230\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/c4f4bd7490f3eb3a48232a5106ce659a?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/c4f4bd7490f3eb3a48232a5106ce659a?s=96&d=mm&r=g\",\"caption\":\"Neil Hodgson\"},\"url\":\"https:\/\/www.thebusinessdesk.com\/northwest\/news\/author\/neilhodgson\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Yourgene Health test receives approval from Australian regulators","description":"Kit can identify patients at increased risk of severe chemotherapy toxicity","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.thebusinessdesk.com\/northwest\/news\/2182640-yourgene-health-test-receives-approval-from-australian-regulators","og_locale":"en_GB","og_type":"article","og_title":"Yourgene Health test receives approval from Australian regulators","og_description":"Kit can identify patients at increased risk of severe chemotherapy toxicity","og_url":"https:\/\/www.thebusinessdesk.com\/northwest\/news\/2182640-yourgene-health-test-receives-approval-from-australian-regulators","og_site_name":"North West","article_published_time":"2026-11-11T07:39:04+00:00","og_image":[{"width":1932,"height":1287,"url":"https:\/\/www.thebusinessdesk.com\/_files\/images\/feb_25\/Lyn-Rees_CEO_Novacyt-e1739529340128.jpg","type":"image\/jpeg"}],"author":"Neil Hodgson","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Neil Hodgson","Estimated reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/www.thebusinessdesk.com\/northwest\/news\/2182640-yourgene-health-test-receives-approval-from-australian-regulators","url":"https:\/\/www.thebusinessdesk.com\/northwest\/news\/2182640-yourgene-health-test-receives-approval-from-australian-regulators","name":"Yourgene Health test receives approval from Australian regulators","isPartOf":{"@id":"https:\/\/www.thebusinessdesk.com\/northwest\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.thebusinessdesk.com\/northwest\/news\/2182640-yourgene-health-test-receives-approval-from-australian-regulators#primaryimage"},"image":{"@id":"https:\/\/www.thebusinessdesk.com\/northwest\/news\/2182640-yourgene-health-test-receives-approval-from-australian-regulators#primaryimage"},"thumbnailUrl":"https:\/\/www.thebusinessdesk.com\/_files\/images\/feb_25\/Lyn-Rees_CEO_Novacyt-e1739529340128.jpg","datePublished":"2026-11-11T07:39:04+00:00","dateModified":"2026-11-11T07:39:04+00:00","author":{"@id":"https:\/\/www.thebusinessdesk.com\/northwest\/#\/schema\/person\/fa48fb423602cb1966a9a546cfe09356"},"description":"Kit can identify patients at increased risk of severe chemotherapy toxicity","breadcrumb":{"@id":"https:\/\/www.thebusinessdesk.com\/northwest\/news\/2182640-yourgene-health-test-receives-approval-from-australian-regulators#breadcrumb"},"inLanguage":"en-GB","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.thebusinessdesk.com\/northwest\/news\/2182640-yourgene-health-test-receives-approval-from-australian-regulators"]}]},{"@type":"ImageObject","inLanguage":"en-GB","@id":"https:\/\/www.thebusinessdesk.com\/northwest\/news\/2182640-yourgene-health-test-receives-approval-from-australian-regulators#primaryimage","url":"https:\/\/www.thebusinessdesk.com\/_files\/images\/feb_25\/Lyn-Rees_CEO_Novacyt-e1739529340128.jpg","contentUrl":"https:\/\/www.thebusinessdesk.com\/_files\/images\/feb_25\/Lyn-Rees_CEO_Novacyt-e1739529340128.jpg","width":1932,"height":1287,"caption":"Lyn Rees"},{"@type":"BreadcrumbList","@id":"https:\/\/www.thebusinessdesk.com\/northwest\/news\/2182640-yourgene-health-test-receives-approval-from-australian-regulators#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.thebusinessdesk.com\/northwest\/"},{"@type":"ListItem","position":2,"name":"Yourgene Health test receives approval from Australian regulators"}]},{"@type":"WebSite","@id":"https:\/\/www.thebusinessdesk.com\/northwest\/#website","url":"https:\/\/www.thebusinessdesk.com\/northwest\/","name":"North West","description":"Regional business news for North West","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.thebusinessdesk.com\/northwest\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-GB"},{"@type":"Person","@id":"https:\/\/www.thebusinessdesk.com\/northwest\/#\/schema\/person\/fa48fb423602cb1966a9a546cfe09356","name":"Neil Hodgson","image":{"@type":"ImageObject","inLanguage":"en-GB","@id":"https:\/\/www.thebusinessdesk.com\/northwest\/#\/schema\/person\/image\/25f0ca12630eea7c4ef70e0e79410230","url":"https:\/\/secure.gravatar.com\/avatar\/c4f4bd7490f3eb3a48232a5106ce659a?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/c4f4bd7490f3eb3a48232a5106ce659a?s=96&d=mm&r=g","caption":"Neil Hodgson"},"url":"https:\/\/www.thebusinessdesk.com\/northwest\/news\/author\/neilhodgson"}]}},"_links":{"self":[{"href":"https:\/\/www.thebusinessdesk.com\/northwest\/wp-json\/wp\/v2\/posts\/2182640","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.thebusinessdesk.com\/northwest\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.thebusinessdesk.com\/northwest\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.thebusinessdesk.com\/northwest\/wp-json\/wp\/v2\/users\/217725"}],"replies":[{"embeddable":true,"href":"https:\/\/www.thebusinessdesk.com\/northwest\/wp-json\/wp\/v2\/comments?post=2182640"}],"version-history":[{"count":1,"href":"https:\/\/www.thebusinessdesk.com\/northwest\/wp-json\/wp\/v2\/posts\/2182640\/revisions"}],"predecessor-version":[{"id":2182641,"href":"https:\/\/www.thebusinessdesk.com\/northwest\/wp-json\/wp\/v2\/posts\/2182640\/revisions\/2182641"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.thebusinessdesk.com\/northwest\/wp-json\/wp\/v2\/media\/2147191"}],"wp:attachment":[{"href":"https:\/\/www.thebusinessdesk.com\/northwest\/wp-json\/wp\/v2\/media?parent=2182640"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.thebusinessdesk.com\/northwest\/wp-json\/wp\/v2\/categories?post=2182640"},{"taxonomy":"author","embeddable":true,"href":"https:\/\/www.thebusinessdesk.com\/northwest\/wp-json\/wp\/v2\/coauthors?post=2182640"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}